Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases
Abstract The use of designer benzodiazepines appears to be increasing in many countries, but data concerning blood concentrations are scarce, making interpretation of concentrations difficult. The aim of this study was to report blood concentrations of clonazolam, diclazepam, etizolam, flualprazolam, flubromazepam, flubromazolam and phenazepam and to investigate the relationship between blood concentrations and impairment. The concentration data are from blood samples collected from living cases (apprehended drivers and other drug offences) and medico-legal autopsies. The blood samples were analysed for
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join ā it's freeAlready a member? Log in
